Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings

Cancer Cytopathol. 2011 Oct 25;119(5):335-45. doi: 10.1002/cncy.20162. Epub 2011 Jun 29.

Abstract

Background: Appropriate treatment of nonsmall cell lung cancer (NSCLC) depended on histologic type. The aim of this study was to evaluate the expression levels of Napsin A, thyroid transcription factor-1 (TTF-1), and p63 by immunostaining using CytoRich Red preserved cytocentrifuged bronchial brushings.

Methods: The expression levels of Napsin A, TTF-1, and p63 were semiquantitatively evaluated using proportion and intensity scores in 12 patients from whom both bronchial brushing cytology and bronchial biopsy samples had been obtained, as well as in a selection of 64 resected NSCLC tissue samples, and 8 normal or benign bronchial brushing cytology samples.

Results: The nuclear expressions of TTF-1 and p63 allowed for good visualization of cancer cells, whereas the cytoplasmic expression of Napsin A in cancer cells was often more difficult to evaluate because medium-sized and large macrophages also expressed Napsin A. Napsin A and TTF-1 were reliable adenocarcinoma markers, and p63 was a reliable squamous cell carcinoma marker in cytology, and histology samples. The average scores of Napsin A, TTF-1, and p63 were highly correlated in bronchial brushing cytology and bronchial biopsy samples, whereas TTF-1 expression was significantly lower than Napsin A expression in resected NSCLC tissue samples (P < .001).

Conclusions: Immunostaining of bronchial brushings fixed with CytoRich Red was useful in determining histologic types in NSCLC. It was suggested that the panels of Napsin A, TTF-1, and p63 were effective in identifying histologic type in NSCLC, and that a combination of either Napsin A and p63 or TTF-1 and p63 should be chosen, depending on morphology.

Publication types

  • Comparative Study

MeSH terms

  • Aspartic Acid Endopeptidases / biosynthesis*
  • Biomarkers, Tumor / biosynthesis
  • Biopsy
  • Bronchi / metabolism*
  • Bronchi / pathology
  • Carcinoma, Non-Small-Cell Lung / metabolism*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Cytodiagnosis / methods
  • Humans
  • Immunohistochemistry
  • Lung Neoplasms / metabolism*
  • Lung Neoplasms / pathology
  • Nuclear Proteins / biosynthesis*
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Thyroid Nuclear Factor 1
  • Transcription Factors / biosynthesis*
  • Tumor Suppressor Proteins / biosynthesis*

Substances

  • Biomarkers, Tumor
  • NKX2-1 protein, human
  • Nuclear Proteins
  • TP63 protein, human
  • Thyroid Nuclear Factor 1
  • Transcription Factors
  • Tumor Suppressor Proteins
  • Aspartic Acid Endopeptidases
  • NAPSA protein, human